Fangming Lin, MD
Overview
Dr. Fangming Lin joined CUMC in June 2011 as the Division Director of Pediatric Nephrology after 10 years of serving University of Texas Southwestern Medical Center at Dallas. She received her MD degree from Fujian Medical University in China and her PhD degree in Pharmacology at New York Medical College. Dr. Lin underwent pediatric residency training at New York University Medical Center and pediatric nephrology fellowship training at Seattle Children’s Hospital of the University of Washington.
As a physician scientist, Dr. Lin has a strong interest in both patient care and science and discovery. She is passionate and experienced in treating children with congenital kidney conditions as well as acquired kidney diseases. Her laboratory research focuses on the understanding and better treatment for acute and chronic kidney disease. She is the first recipient of the Norman Siegel Pediatric Research Grant Award jointly issued by the American Society of Nephrology (ASN) and the American Society of Pediatric Nephrology (ASPN) in 2006 - a humbling selection of which she is proud. Dr. Lin has also served on several committees at the national and international levels.
Email: fl2300@cumc.columbia.edu
Areas of Expertise / Conditions Treated
- Glomerulonephritis
- Hematuria
- Hemodialysis
- Hemolytic Uremic Syndrome
- Hypertension
- Kidney Stones
- Kidney Transplant
- Kidney Transplantation
- Nephrotic Syndrome
- Peritoneal Dialysis
- Proteinuria
Academic Appointments
- Rustin McIntosh Professor of Pediatrics
Administrative Titles
- Chief, Division of Pediatric Nephrology
Hospital Affiliations
- NewYork-Presbyterian / Columbia University Irving Medical Center
- NewYork-Presbyterian Morgan Stanley Children's Hospital
- NewYork-Presbyterian Allen Hospital
Gender
- Female
Schedule an Appointment
Virtual Visits/Telehealth
Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.
Phone Appointments
Connect Patient Portal
For existing patients, login to make an appointment, view documentation or contact your care provider.
Location(s)
Insurance Accepted
Aetna
- Aetna Signature Administrators
- NY Signature
- Student Health
Affinity Health Plan
- Medicaid Managed Care
Amerigroup of New Jersey
- New Jersey Services (Medicaid Managed Care)
Cigna
- EPO
- Great West (National)
- HMO
- Medicare Managed Care
- POS
- PPO
Emblem/GHI
- Medicare Managed Care
- PPO
Emblem/HIP
- ConnectiCare
- EPO
- Essential Plan
- HMO
- Medicare Managed Care
- POS
- PPO
- Select Care (Exchange)
- Vytra
Empire Blue Cross Blue Shield HealthPlus
- Child/Family Health Plus
- Essential Plan
Fidelis Care
- Essential Plan
- Medicaid Managed Care
- Medicare Managed Care
Healthfirst
- Child/Family Health Plus
- Leaf (Exchange)
- Medicare Managed Care
Local 1199
- Local 1199
- NYP Employee Plan
MagnaCare (National)
- MagnaCare
Medicare
- Railroad
- Traditional Medicare
Multiplan
- Multiplan
MVP Health Care
- Child/Family Health Plus
- Essential Plan
- HMO
- Medicaid Managed Care
Quality Health Management
- Quality Health Management
UnitedHealthcare
- Compass (Exchange)
- Empire Plan
- HMO
- Medicaid (Community Plan)
- Oxford Freedom
- Oxford HMO
- Oxford Liberty
- POS
- PPO
VNSNY CHOICE
- SelectHealth
- Special Needs
WellCare
- Medicare Managed Care
World Trade Center Health Plan
- World Trade Center Health Plan
Credentials & Experience
Education & Training
- Fujian Medical University (China)
- Internship: New York University Medical Center
- Residency: New York University Medical Center
- Fellowship: Seattle Children's Hospital
Board Certifications
- Pediatrics
- Pediatric Nephrology
Research
Our laboratory studies kidney injury and repair using a variety of mouse models. We are currently focusing on the function and molecular regulation of epithelial autophagy. We have shown that following urinary tract obstruction or ischemic injury to the kidney, autophagy is activated in a regulated and dynamic fashion for renal tubular survival and repair. A stress-responsive transcription factor FoxO3 plays an important role in regulating the stress response during the acute injury and the progression to chronic kidney disease. Our goal is to use the knowledge learned from animal studies to help design methods that integrate modulation of autophagy into prevention and treatment for human kidney disease.
Grants
GENERATION OF NEW MOUSE MODELS OF LOW NEPHRON NUMBERS TO UNDERSTAND PATHOGENESIS OF AKI AND CKD IN HUMANS BORN PRETERM (Federal Gov)
Feb 15 2019 - November 30 2022
For a complete list of publications, please visit PubMed.gov